1Kirklin JK, Westaby S, Butter J, et al. Complement and the damaging effects of cardiopulmonary bypass [J]. J Thorac Cardiovasc Surg, 1983,86: 857-859. 被引量：1
2Tennemberg SD, Clardy CW, Smith LJ, et al. Complement activation and lung permeability during cardiopulmonary bypass[J]. Ann Thorac Surg, 1990,50 : 597-601. 被引量：1
3Butler J, Gu YJ, Gatfin SL, et al. Inflammatory response to cardiopulmonary bypass [J]. Ann Thorac Surg, 1993,55:552-559. 被引量：1
4El Hubbal MH,Smith LJ. Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules[J]. Cardiovasc Res, 1997,33 : 209-215. 被引量：1
5Cremer J, Martin M, Killbridge PM, et al. Systemic inflammatory response syndrome after cardiac operations[J]. Ann Thorac Surg,1996,61:1714-1720. 被引量：1
6Rocke DA, Gaffin SL, Smith L J, et al. Endotoxemia associated with cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 1987,93: 832-837. 被引量：1
7Edward M, Boyle J, Smith L J, et al. Endothelial cell injury in cardiovascular surgery the systemic inflammatory response[J]. Ann Thorac Surg, 1997,63:277-284. 被引量：1
8Miller BE, Levy JH. The inflammatory response to cardiopulmanan bypass [J]. J Cardiothorac Vase Anesth,1997,11:355-366. 被引量：1
9Grundy SM,Bazzarre T, cleeman J, et al. Prevention conference V: beyond secondary prevention., identifying the high-risk patient for primary prevention[J]. Circulation,2000,101 :e3-e11. 被引量：1
10Roberts WL, Mouton L,Law TC, et al. Evluation of nine anomated high sensitivity C-reactive protein methods : implications for clinical and epidemiological applications[J].Clin Chem,2001,47:418-423. 被引量：1
10Lazar,Harold L,Bokesch MD,et al.Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass[J].Circulation,2004,110(11)Supplement:274-279. 被引量：1
